Neal Masia is co-founder and CEO of EntityRisk, Inc., a company using cutting-edge health economics to make treatment outcomes more predictable and more investable. He is also the founder of Health Capital Group, LLC, which advises healthcare companies ranging from startups to public corporations and major investment and consulting firms including Guggenheim Partners, Blackstone and EY. Prior to his current roles, Neal spent 18 years at Pfizer Inc. As a member of Pfizer’s Senior Leadership Council, Neal advised the Executive Leadership Team and Board of Directors on how global economic forces shape the healthcare industry and he worked closely with the CFO on all strategic business development activities. Over the course of his Pfizer career, Neal built or redesigned major commercial and finance functions including Capital Strategy, International Treasury, Global Pricing, Real World Data and Analytics, Patient-Centered Outcomes, and Market Access/HTA Methods and Capabilities. Prior to Pfizer, Neal was a consultant at the Advisory Board Company, a special studies analyst with the U.S. Congressional Budget Office, a director of planning and marketing at a venture-backed insurance technology startup, and a senior policy advisor to Senator Bill Bradley. He has been an Adjunct Professor of Management and Economics at Columbia University since 2013, and serves on several boards including CaliberMRI and Jewish Family and Children’s Services. Neal earned a B.A. (High Honors) in Mathematical Economics from Colgate University and a Ph.D. in Economics (specializing in Public Finance and Game Theory) from the University of Rochester.
9:00 AM - 10:00 AM (PDT)
Thursday, June 16
Improvements in care benefit patients but make it harder to demonstrate survival gains in…